4.8 Article

ZnS@BSA Nanoclusters Potentiate Efficacy of Cancer Immunotherapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma: A Review

Matthias Pinter et al.

Summary: Recent advancements in the treatment of advanced hepatocellular carcinoma (HCC) have led to the approval of new systemic therapies such as angiogenesis inhibitors and immune checkpoint blockers, indicating important progress in the field. Strategies to target immunosuppression in tumors, such as vascular endothelial growth factor pathway inhibition and transforming growth factor-beta pathway inhibition, show promise in enhancing the efficacy of immunotherapy in HCC. Successes and failures of these treatments have provided insights into implementing novel systemic therapy in HCC and improving immunotherapy efficacy for this disease.

JAMA ONCOLOGY (2021)

Article Chemistry, Multidisciplinary

Nanoparticle-Mediated Delivery of Inhaled Immunotherapeutics for Treating Lung Metastasis

Qiutong Jin et al.

Summary: This study developed an inhaled immunotherapeutic chitosan-antibody complex that effectively activates the immune system, promotes infiltration of different immune cells around tumor lesions, and prolongs the survival of mice.

ADVANCED MATERIALS (2021)

Article Engineering, Biomedical

In situ activation of STING pathway with polymeric SN38 for cancer chemoimmunotherapy

Jiayu Zhao et al.

Summary: The study presented a method for in situ activation of the STING pathway using nanoparticles to deliver DNA-targeting chemo agents, demonstrating the potent ability of SN38 in stimulating interferon secretion and activating the STING pathway. The nanoparticle formulation effectively stimulated STING pathway activation, resulting in significant tumor suppression.

BIOMATERIALS (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Chemistry, Multidisciplinary

Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration

Mohamed Wehbe et al.

Summary: The STING pathway is crucial in cancer immunosurveillance and STING-NPs show promising potential in remodeling TME and enhancing immunotherapy responses. Nanocarrier delivery of cGAMP improves its accumulation in tumors and activation of STING pathway, resulting in reprogramming of TME towards an immunogenic milieu with increased T-cell infiltration and improved response to immunotherapy.

JOURNAL OF CONTROLLED RELEASE (2021)

Article Medicine, Research & Experimental

Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance

Meng Zhao et al.

Summary: Reducing mtROS levels attenuated renal dysfunction, mitochondrial damage, and inflammation in IRI-AKI mice. The loss of TFAM can impact mtDNA maintenance, mitochondrial energy metabolism, and cytokine release. Insights into the role of mtROS and TFAM in IRI-AKI provide potential therapeutic targets for renal repair.

THERANOSTICS (2021)

Review Oncology

The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer

John Kwon et al.

CANCER DISCOVERY (2020)

Article Chemistry, Multidisciplinary

FeS@BSA Nanoclusters to Enable H2S-Amplified ROS-Based Therapy with MRI Guidance

Congkun Xie et al.

ADVANCED SCIENCE (2020)

Article Nanoscience & Nanotechnology

A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing

Guojun Chen et al.

NATURE NANOTECHNOLOGY (2019)

Review Gastroenterology & Hepatology

A global view of hepatocellular carcinoma: trends, risk, prevention and management

Ju Dong Yang et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Multidisciplinary Sciences

DNA-induced liquid phase condensation of cGAS activates innate immune signaling

Mingjian Du et al.

SCIENCE (2018)

Review Oncology

Cancer nanomedicine: progress, challenges and opportunities

Jinjun Shi et al.

NATURE REVIEWS CANCER (2017)

Article Chemistry, Multidisciplinary

Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise

Qian Chen et al.

ADVANCED MATERIALS (2016)

Article Chemistry, Multidisciplinary

Synthesis of Iron Nanometallic Glasses and Their Application in Cancer Therapy by a Localized Fenton Reaction

Chen Zhang et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)

Editorial Material Cell Biology

Innate Immune Recognition of mtDNA-An Undercover Signal?

Thirumala-Devi Kanneganti et al.

CELL METABOLISM (2015)

Review Physiology

MITOCHONDRIAL REACTIVE OXYGEN SPECIES (ROS) AND ROS-INDUCED ROS RELEASE

Dmitry B. Zorov et al.

PHYSIOLOGICAL REVIEWS (2014)